Details for New Drug Application (NDA): 204872
✉ Email this page to a colleague
The generic ingredient in NAPROXEN SODIUM is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
Summary for 204872
Tradename: | NAPROXEN SODIUM |
Applicant: | Lnk Intl Inc |
Ingredient: | naproxen sodium |
Patents: | 0 |
Pharmacology for NDA: 204872
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 204872
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 204872 | ANDA | Rite Aid Corporation | 11822-4170 | 11822-4170-5 | 1 BOTTLE, PLASTIC in 1 CARTON (11822-4170-5) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 204872 | ANDA | Rite Aid Corporation | 11822-4171 | 11822-4171-2 | 1 BOTTLE, PLASTIC in 1 CARTON (11822-4171-2) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 220MG | ||||
Approval Date: | Jan 23, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription